MediWound Ltd

NASDAQ:MDWD   3:59:51 PM EDT
3.90
+0.10 (+2.63%)
Products

Mediwound Announces Escharex Phase 2 Trial Results Published In The Online Wound Repair And Regeneration Journal

Published: 07/09/2021 12:14 GMT
MediWound Ltd (MDWD) - Mediwound Announces Peer-reviewed Paper Detailing Escharex Phase 2 Randomized Control Trial Results Published in the Online Wound Repair and Regeneration Journal.
Mediwound Ltd - Study Findings Demonstrate Strong Results in Debriding Venous Leg Ulcers and Diabetic Foot Ulcers.
Mediwound Ltd - Interim Assessment of Ongoing U.S. Phase Ii Adaptive Design Study in Venus Leg Ulcers Expected End of July 2021.